NKTR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.71%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $377,218.13

Nektar Therapeutics Insider Trading History Chart

Nektar Therapeutics Share Price & Price History

^$0.74

▼ -0.0178 (-2.35%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Nektar Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/19/2025	Howard W Robin	CEO	Sell	23,774	$1.01	$24,011.74	1,086,901
2/19/2025	Jonathan Zalevsky	Insider	Sell	10,300	$1.01	$10,403.00	316,604
12/23/2024	Mark Andrew Wilson	Insider	Sell	33,402	$0.90	$30,061.80	351,892
12/19/2024	Jonathan Zalevsky	Insider	Sell	51,115	$0.94	$48,048.10	326,904
12/17/2024	Howard W Robin	CEO	Sell	46,995	$1.01	$47,464.95	1,195,710
11/19/2024	Howard W Robin	CEO	Sell	16,278	$1.01	$16,440.78	832,080
11/19/2024	Jonathan Zalevsky	Insider	Sell	7,785	$1.01	$7,862.85	243,019
8/19/2024	Howard W Robin	CEO	Sell	14,881	$1.28	$19,047.68	848,358
8/19/2024	Jonathan Zalevsky	Insider	Sell	6,866	$1.28	$8,788.48	250,804
6/14/2024	Robert Chess	Director	Sell	19,500	$1.20	$23,400.00	255,273
5/17/2024	Howard W Robin	CEO	Sell	16,650	$1.75	$29,137.50	863,239
5/17/2024	Jonathan Zalevsky	Insider	Sell	7,355	$1.75	$12,871.25	257,670
5/10/2024	Deep Track Capital, Lp	Major Shareholder	Sell	56,000	$1.78	$99,680.00	18,344,000
2/20/2024	Howard W Robin	CEO	Sell	20,033	$0.68	$13,622.44	879,889
2/20/2024	Jonathan Zalevsky	Insider	Sell	9,014	$0.68	$6,129.52	265,025
11/17/2023	Howard W Robin	CEO	Sell	19,877	$0.49	$9,739.73	899,922
11/17/2023	Jonathan Zalevsky	Insider	Sell	9,646	$0.49	$4,726.54	274,039
9/18/2023	Myriam Curet	Director	Sell	4,359	$0.69	$3,007.71	27,418
8/16/2023	Howard W Robin	CEO	Sell	19,998	$0.78	$15,598.44	919,799
8/16/2023	Jonathan Zalevsky	Insider	Sell	9,703	$0.78	$7,568.34	283,685
6/14/2023	Roy A Whitfield	Director	Sell	30,000	$0.57	$17,100.00	216,250
5/16/2023	Howard W Robin	CEO	Sell	20,361	$0.72	$14,659.92	939,797
5/16/2023	Jonathan Zalevsky	Insider	Sell	9,791	$0.72	$7,049.52	293,388
2/16/2023	Howard W Robin	CEO	Sell	19,635	$3.00	$58,905.00	960,158
2/16/2023	Jillian B. Thomsen	CFO	Sell	10,267	$3.00	$30,801.00	313,497
2/16/2023	Jonathan Zalevsky	Insider	Sell	10,484	$3.00	$31,452.00	303,179
11/16/2022	Howard W Robin	CEO	Sell	38,014	$3.57	$135,709.98	979,793
11/16/2022	Jillian B. Thomsen	CFO	Sell	11,095	$3.57	$39,609.15	323,764
11/16/2022	Jonathan Zalevsky	Insider	Sell	13,460	$3.57	$48,052.20	313,663
9/23/2022	Myriam Curet	Director	Sell	4,198	$3.16	$13,265.68	31,777
9/13/2022	Karin Eastham	Director	Sell	21,267	$3.61	$76,773.87	13,033
8/18/2022	Jonathan Zalevsky	Insider	Sell	73,716	$4.65	$342,779.40	327,123
8/16/2022	Howard W Robin	CEO	Sell	13,759	$4.76	$65,492.84	1,017,807
8/16/2022	Jillian B. Thomsen	CAO	Sell	2,006	$4.76	$9,548.56	334,859
8/16/2022	Jonathan Zalevsky	Insider	Sell	10,560	$4.76	$50,265.60	400,839
8/16/2022	Mark Andrew Wilson	SVP	Sell	3,189	$4.76	$15,179.64	281,188
5/16/2022	Gil M. Labrucherie	CFO	Sell	17,448	$3.95	$68,919.60	312,905
5/16/2022	Howard W Robin	CEO	Sell	36,529	$3.95	$144,289.55	620,941
5/16/2022	Jillian B. Thomsen	CAO	Sell	5,841	$3.95	$23,071.95	170,427
5/16/2022	Jonathan Zalevsky	Insider	Sell	21,673	$3.95	$85,608.35	276,399
5/16/2022	Mark Andrew Wilson	SVP	Sell	3,136	$3.95	$12,387.20	117,939

See Full Table

SEC Filings (Institutional Ownership Changes) for Nektar Therapeutics (NASDAQ:NKTR)

75.88% of Nektar Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nektar Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	522,409	$0.49M	0.0%	+10.4%	0.281%
2/20/2025	Mackenzie Financial Corp	469,769	$0.44M	0.0%	+801.4%	0.255%
2/19/2025	Public Employees Retirement System of Ohio	142,064	$0.13M	0.0%	-10.7%	0.077%
2/18/2025	US Asset Management LLC	33,484	$31K	0.0%	N/A	0.018%
2/17/2025	Woodline Partners LP	4,974,512	$4.63M	0.0%	+187.3%	2.697%
2/17/2025	Squarepoint Ops LLC	139,758	$0.13M	0.0%	N/A	0.076%
2/17/2025	Two Sigma Advisers LP	1,486,242	$1.38M	0.0%	-0.9%	0.806%
2/17/2025	Two Sigma Investments LP	1,537,355	$1.43M	0.0%	+12.8%	0.833%
2/17/2025	Shay Capital LLC	352,204	$0.33M	0.0%	-77.9%	0.191%
2/17/2025	ProShare Advisors LLC	50,277	$47K	0.0%	+49.0%	0.027%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,580,916	$1.47M	0.1%	+37.4%	0.857%
2/17/2025	Millennium Management LLC	4,524,946	$4.21M	0.0%	-10.6%	2.453%
2/17/2025	Jacobs Levy Equity Management Inc.	2,626,961	$2.44M	0.0%	-6.0%	1.424%
2/17/2025	Graham Capital Management L.P.	96,911	$90K	0.0%	+408.5%	0.053%
2/17/2025	D. E. Shaw & Co. Inc.	175,193	$0.16M	0.0%	+267.0%	0.095%
2/17/2025	Deep Track Capital LP	1,975,998	$1.84M	0.1%	-87.6%	1.071%
2/17/2025	Bridgeway Capital Management LLC	1,292,100	$1.20M	0.0%	-5.1%	0.700%
2/17/2025	Bank of America Corp DE	207,267	$0.19M	0.0%	-5.0%	0.112%
2/17/2025	BNP Paribas Financial Markets	312,693	$0.29M	0.0%	+30.9%	0.170%
2/17/2025	Ameriprise Financial Inc.	373,948	$0.35M	0.0%	+32.8%	0.203%
2/17/2025	22NW LP	2,191,750	$2.04M	1.5%	N/A	1.188%
2/14/2025	Nantahala Capital Management LLC	7,810,000	$7.26M	0.3%	+90.0%	4.234%
2/14/2025	Northern Trust Corp	1,414,984	$1.32M	0.0%	+0.9%	0.767%
2/14/2025	Boothbay Fund Management LLC	555,876	$0.52M	0.0%	+59.3%	0.301%
2/14/2025	Two Sigma Securities LLC	27,654	$26K	0.0%	+56.3%	0.015%
2/14/2025	Voya Investment Management LLC	181,679	$0.17M	0.0%	+200.3%	0.098%
2/14/2025	Price T Rowe Associates Inc. MD	192,978	$0.18M	0.0%	+6.0%	0.105%
2/14/2025	Harvest Investment Services LLC	29,244	$27K	0.0%	N/A	0.016%
2/14/2025	Diadema Partners LP	698,919	$0.65M	0.3%	N/A	0.379%
2/14/2025	Altium Capital Management LLC	3,000,000	$2.79M	0.8%	+26,172.0%	1.626%
2/13/2025	XTX Topco Ltd	244,701	$0.23M	0.0%	+595.8%	0.133%
2/13/2025	Barclays PLC	325,818	$0.30M	0.0%	-9.1%	0.177%
2/13/2025	Renaissance Technologies LLC	3,910,786	$3.64M	0.0%	+17.5%	2.120%
2/13/2025	Russell Investments Group Ltd.	67,829	$63K	0.0%	-24.2%	0.037%
2/13/2025	Wells Fargo & Company MN	108,975	$0.10M	0.0%	+26.5%	0.059%
2/12/2025	Wellington Management Group LLP	522,409	$0.49M	0.0%	+10.4%	0.283%
2/12/2025	JPMorgan Chase & Co.	1,182,995	$1.10M	0.0%	+29.5%	0.641%
2/11/2025	Sei Investments Co.	94,152	$88K	0.0%	+50.6%	0.051%
2/10/2025	Primecap Management Co. CA	5,540,386	$5.15M	0.0%	-6.3%	3.004%
2/10/2025	Monaco Asset Management SAM	2,032,868	$1.89M	0.3%	+1.8%	1.102%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	730,875	$0.68M	0.0%	+12.3%	0.396%
1/29/2025	Peapod Lane Capital LLC	1,107,516	$1.03M	1.0%	N/A	0.600%
1/28/2025	Moloney Securities Asset Management LLC	50,000	$46K	0.0%	+42.4%	0.027%
1/17/2025	SG Americas Securities LLC	107,318	$100K	0.0%	+12.2%	0.058%
1/15/2025	HB Wealth Management LLC	64,100	$60K	0.0%	+44.0%	0.035%
12/26/2024	JPMorgan Chase & Co.	913,300	$1.19M	0.0%	+197.3%	0.495%
11/19/2024	Barclays PLC	358,294	$0.47M	0.0%	+96.1%	0.194%
11/16/2024	Geode Capital Management LLC	3,963,083	$5.15M	0.0%	-3.6%	2.149%
11/15/2024	Barclays PLC	358,294	$0.47M	0.0%	+96.1%	0.194%
11/15/2024	XTX Topco Ltd	35,170	$46K	0.0%	N/A	0.019%
11/15/2024	Jane Street Group LLC	91,470	$0.12M	0.0%	+50.0%	0.050%
11/15/2024	Wellington Management Group LLP	473,090	$0.62M	0.0%	N/A	0.256%
11/15/2024	State Street Corp	3,345,733	$4.35M	0.0%	+11.9%	1.814%
11/15/2024	Jacobs Levy Equity Management Inc.	2,793,204	$3.63M	0.0%	-2.8%	1.514%
11/15/2024	Erste Asset Management GmbH	46,800	$61K	0.0%	N/A	0.025%
11/14/2024	Eventide Asset Management LLC	9,400,000	$12.22M	0.2%	+24.8%	5.096%
11/14/2024	MetLife Investment Management LLC	106,506	$0.14M	0.0%	+129.1%	0.058%
11/13/2024	BNP Paribas Financial Markets	238,846	$0.31M	0.0%	+1,877.2%	0.129%
11/13/2024	FMR LLC	386,656	$0.50M	0.0%	+403.2%	0.210%
11/13/2024	The Manufacturers Life Insurance Company	66,218	$86K	0.0%	N/A	0.036%
11/12/2024	Valence8 US LP	26,107	$34K	0.0%	N/A	0.014%
11/12/2024	Charles Schwab Investment Management Inc.	1,454,168	$1.89M	0.0%	-2.3%	0.790%
11/9/2024	Primecap Management Co. CA	5,912,453	$7.69M	0.0%	-1.8%	3.212%
11/9/2024	Intech Investment Management LLC	31,249	$41K	0.0%	N/A	0.017%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	650,841	$0.85M	0.0%	+5.6%	0.354%
11/5/2024	GSA Capital Partners LLP	214,245	$0.28M	0.0%	-77.0%	0.116%
10/30/2024	Moloney Securities Asset Management LLC	35,105	$46K	0.0%	-58.8%	0.019%
10/3/2024	SG Americas Securities LLC	95,637	$0.12M	0.0%	+30.4%	0.052%
8/20/2024	Nantahala Capital Management LLC	4,110,000	$5.10M	0.3%	+66.0%	2.233%
8/15/2024	Mackenzie Financial Corp	43,765	$54K	0.0%	-54.9%	0.024%
8/15/2024	Millennium Management LLC	4,659,469	$5.78M	0.0%	+56.1%	2.532%
8/15/2024	Armistice Capital LLC	836,000	$1.04M	0.0%	N/A	0.454%
8/14/2024	Samlyn Capital LLC	9,457,887	$11.73M	0.2%	N/A	5.140%
8/9/2024	Primecap Management Co. CA	6,020,453	$7.47M	0.0%	-13.6%	3.272%
8/9/2024	Renaissance Technologies LLC	3,313,833	$4.11M	0.0%	-28.3%	1.801%
8/9/2024	Dimensional Fund Advisors LP	515,998	$0.64M	0.0%	-5.1%	0.280%
8/7/2024	Monaco Asset Management SAM	2,166,432	$2.69M	0.4%	-62.8%	1.177%
8/6/2024	Acadian Asset Management LLC	4,884,594	$6.06M	0.0%	-35.5%	2.654%
8/6/2024	Candriam S.C.A.	79,594	$99K	0.0%	N/A	0.043%
8/5/2024	Acuitas Investments LLC	879,904	$1.09M	0.6%	-31.3%	0.478%
8/5/2024	Victory Capital Management Inc.	23,031	$29K	0.0%	N/A	0.013%
8/2/2024	CM Management LLC	750,000	$0.93M	0.8%	-20.2%	0.408%
8/1/2024	Rhumbline Advisers	185,116	$0.23M	0.0%	+3,377.0%	0.101%
7/30/2024	Moloney Securities Asset Management LLC	85,105	$0.11M	0.0%	-19.0%	0.046%
7/26/2024	Bank of New York Mellon Corp	551,535	$0.68M	0.0%	+2,822.5%	0.300%
7/19/2024	Values First Advisors Inc.	45,197	$56K	0.0%	N/A	0.025%
7/12/2024	SG Americas Securities LLC	73,352	$91K	0.0%	+63.0%	0.040%
5/30/2024	Lynx1 Capital Management LP	2,068,842	$1.93M	0.5%	+7.2%	1.127%
5/16/2024	Jacobs Levy Equity Management Inc.	1,911,186	$1.79M	0.0%	-43.9%	1.041%
5/15/2024	Public Employees Retirement System of Ohio	169,749	$0.16M	0.0%	-38.3%	0.092%
5/10/2024	Acadian Asset Management LLC	7,569,063	$7.07M	0.0%	-3.2%	4.122%
5/10/2024	Vanguard Group Inc.	12,049,138	$11.26M	0.0%	+0.1%	6.562%
5/9/2024	Monaco Asset Management SAM	5,831,565	$5.45M	1.6%	-2.4%	3.176%
5/9/2024	State Board of Administration of Florida Retirement System	67,437	$63K	0.0%	N/A	0.037%
5/8/2024	Russell Investments Group Ltd.	82,434	$77K	0.0%	-26.9%	0.045%
5/7/2024	SG Americas Securities LLC	45,014	$42K	0.0%	-55.7%	0.025%
5/7/2024	Marquette Asset Management LLC	232,289	$0.22M	0.0%	+24.8%	0.127%
5/3/2024	GSA Capital Partners LLP	1,989,905	$1.86M	0.1%	-62.1%	1.084%
5/2/2024	Moloney Securities Asset Management LLC	105,105	$98K	0.0%	-8.7%	0.057%
4/24/2024	Assenagon Asset Management S.A.	1,687,300	$1.58M	0.0%	-31.6%	0.919%

Data available starting January 2016

See Full Table

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 2b clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1 clinical trial to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.

Today's Range

Now: $0.74

$0.74

$0.79

50 Day Range

MA: $0.85

$0.66

$1.06

52 Week Range

Now: $0.74

$0.65

$1.93

Volume

1,300,968 shs

Average Volume

1,885,538 shs

Market Capitalization

$137.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65

Who are the company insiders with the largest holdings of Nektar Therapeutics?: Nektar Therapeutics' top insider investors include:
Deep Track Capital, Lp (Major Shareholder)
Howard W Robin (CEO)
Mark Andrew Wilson (Insider)
Jonathan Zalevsky (Insider)
Robert Chess (Director)
Roy A Whitfield (Director)
Myriam Curet (Director)
Learn More about top insider investors at Nektar Therapeutics.
Who are the major institutional investors of Nektar Therapeutics?: Nektar Therapeutics' top institutional shareholders include:
Nantahala Capital Management LLC — 4.23%
Primecap Management Co. CA — 3.00%
Woodline Partners LP — 2.70%
Millennium Management LLC — 2.45%
Renaissance Technologies LLC — 2.12%
Altium Capital Management LLC — 1.63%
Learn More about top institutional investors of Nektar Therapeutics stock.
Which major investors are selling Nektar Therapeutics stock?: Within the previous quarter, NKTR stock was sold by these institutional investors:
Deep Track Capital LP
Shay Capital LLC
Millennium Management LLC
Primecap Management Co. CA
Jacobs Levy Equity Management Inc.
Bridgeway Capital Management LLC
Barclays PLC
Russell Investments Group Ltd.
In the previous year, company insiders that have sold Nektar Therapeutics company stock include:
Deep Track Capital, Lp (Major Shareholder)
Howard W Robin (CEO)
Mark Andrew Wilson (Insider)
Jonathan Zalevsky (Insider)
Robert Chess (Director)
Learn More investors selling Nektar Therapeutics stock.
Which major investors are buying Nektar Therapeutics stock?: In the last quarter, NKTR stock was purchased by institutional investors including:
Nantahala Capital Management LLC
Woodline Partners LP
Altium Capital Management LLC
22NW LP
Peapod Lane Capital LLC
Diadema Partners LP
Renaissance Technologies LLC
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC